查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2095764

急性腦室外引流市場－2026-2032年全球市場預測

Acute External Ventricular Drain Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，急性腦室外引流市場將成長至 5.5551 億美元，複合年成長率為 8.43%。

主要市場統計數據
基準年 2025 3.151億美元
預計年份：2026年 3.4081億美元
預測年份 2032 5.5551億美元
複合年成長率 (%) 8.43%

急性腦室外引流術執行摘要

急性腦室外引流（EVD）系統是一種重要的神經外科醫療器械，用於暫時引流腦脊髓液（CSF）和監測顱內壓（ICP），適用於患有危及生命的神經系統疾病的患者，例如創傷性腦損傷、水腦症、腦室感染疾病、急性腦積水、中樞神經系統感染以及醫療設備後併發症。在急診護理中，EVD置入有助於快速控制ICP，方便收集腦脊髓液，並使臨床醫生能夠透過密切的神經系統監測來應對繼發性腦損傷的風險。

急性伊波拉病毒疾病領域的變革性變化

急性腦室外引流（EVD）領域正從以操作為中心的模式轉向以規範化流程為基礎、數位化支援的神經重症監護。醫院越來越重視實證EVD方案，包括標準化的置管檢查清單、合理使用抗生素、保持敷料無菌、封閉式系統操作以及明確的腦脊髓液採集標準。這種轉變反映了醫療機構日益重視減少醫療設備相關感染、加強病人安全管治以及最大限度減少不必要的臨床差異。

人工智慧對急性伊波拉病毒病護理的累積影響

人工智慧 (AI) 正透過臨床決策支援、預測分析、影像引導規劃、工作流程自動化和品質監控，開始影響急性腦室外引流的生態系統。在神經重症監護領域，人們正在探索利用 AI 模型分析顱內壓 (ICP) 趨勢、波形模式、神經系統觀察、實驗室數據、影像學觀察、藥物暴露情況和通氣參數，以便比僅使用傳統的閾值的監測方法更早地識別病情惡化的風險。

關於急性期引入腦室外引流的關鍵區域性見解

亞太地區的特徵是神經外科手術能力不斷提升，中風和創傷性腦損傷負擔日益加重，以及都市三級醫療機構與農村或資源匱乏地區在獲得先進神經重症監護方面存在差距。在老年人口眾多且急診醫學投入不斷增加的國家，對急性腦脊髓液引流、顱內壓監測和水腦症治療的需求日益成長，而培訓、成本效益、神經影像學的可及性和轉診系統仍然是影響這些技術應用的關鍵因素。

北約、七國集團、金磚國家、歐盟、東協和海灣合作理事會的關鍵群體特定見解

在北約成員國，尤其是在那些擁有完善的軍民創傷救治體系的國家，快速神經創傷管理、標準化緊急應變和重症監護準備至關重要。 EVD（腦血管疾病）在這些國家的重要性體現在創傷性腦損傷的治療、神經外科領域的互通性、災害應對準備、復健路徑以及民用和國防醫療保健系統間品管的急性護理方案等方面。

關於急性腦室外引流（EVD）使用情況的關鍵國家見解。

在中國，神經外科和重症監護體係正在迅速發展，這得益於對三級醫院、中風中心、急診醫療基礎設施和數位化醫院系統的大規模投資。在美國，急性腦室外引流（EVD）的治療環境高度發達，擁有龐大的神經加護病房（Neuro-ICU）容量、創傷中心網路、卒中認證項目以及完善的感染預防和監測系統。臨床實施以標準化的顱內壓（ICP）監測、多學科ICU團隊、電子健康記錄以及降低導管相關感染風險為指導。在日本，憑藉其成熟的神經外科體系、大規模的老齡人口和完善的中風治療基礎設施，EVD在急性水腦症和出血性神經系統急症中的管理至關重要。

關於急性伊波拉病毒疾病的產業領導者實用建議

產業領導者應優先考慮經臨床檢驗的創新，以提高急性腦室外引流（EVD）照護的安全性、工作流程效率和一致性。產品開發應著重於降低感染風險、採用安全的封閉式系統設計、實現可靠的引流控制、提高導管可見度、簡化水平調節和監測、實現精確的壓力測量、確保可靠的連接性以及與重症監護室（ICU）數位基礎設施的兼容性。由於床邊操作直接影響患者安全，因此與神經外科醫生、重症監護醫生和神經重症監護護士進行可用性測試至關重要。

急性腦室外引流分析的調查方法

調查方法分析急性腦室外引流術的現況。二手資料包括同行評審的神經外科和神經重症監護文獻、臨床實踐指南、醫院感染控制標準、醫療設備監管文件、關於神經系統疾病負擔的公共衛生數據、創傷和卒中護理框架、ICU質量改進方面的出版物以及醫療保健系統基礎設施方面的參考文獻。尤其重視權威資訊來源，例如臨床學會、政府衛生機構、監管機構、公共衛生組織和索引科學期刊。

結論：促進更安全的急性腦室外引流照護。

急性腦室外引流系統在急診神經外科和神經重症監護中仍然至關重要，它能夠對有神經功能快速惡化風險的患者進行臨時腦脊髓液引流和顱內壓監測。該領域正朝著更安全、更標準化和數位化驅動的護理模式發展，感染預防、工作流程可靠性、準確的顱內壓監測以及多學科診療方案的遵循已成為關鍵優先事項。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：急性期外腦室引流市場：依產品類型分類

  • 腦室外引流系統
  • 心室導管
  • 排水收集系統
  • 配件
    • 連接器和旋塞
    • 套管針

第8章：急性期腦室外引流市場：依手術類型分類

  • 緊急腦室引流
  • 臨時腦脊髓液引流
  • 神經外科手術後引流
  • ICP監測程序
  • 水腦症的治療

第9章：急性期腦室外引流市場：依引流類型分類

  • 連續排水
  • 間歇性排水

第10章：急性護理外腦室引流市場：依應用領域分類

  • 水腦症的治療
  • 顱內壓監測
  • 蜘蛛網膜下腔出血的治療
  • 創傷性腦損傷的治療

第11章：急性期腦室外引流市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科診所

第12章：急性期腦室外引流市場：依病患年齡層別分類

  • 成人
  • 兒童

第13章：急性期腦室外引流市場：依地區分類

  • 亞太地區
  • 歐洲
  • 北美洲
  • 拉丁美洲
  • 非洲
  • 中東

第14章：急性期腦室外引流市場：依組別分類

  • NATO
  • G7
  • BRICS
  • EU
  • ASEAN
  • GCC

第15章：急性期腦室外引流市場：依國家分類

  • 中國
  • 美國
  • 日本
  • 印度
  • 德國
  • 英國
  • 澳洲
  • 法國
  • 韓國
  • 義大利
  • 加拿大
  • 俄羅斯
  • 巴西
  • 墨西哥
  • 西班牙

第16章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Argi Grup
  • B. Braun SE
  • Christoph Miethke GmbH & Co. KG
  • Cook Medical LLC
  • Desu Medical
  • Fuji Systems Corporation
  • Integra LifeSciences Holdings Corporation
  • Medtronic plc
  • Moller Medical GmbH
  • Natus Medical Incorporated
  • Neuromedex GmbH
  • Raumedic AG
  • Sophysa
  • Spiegelberg GmbH & Co. KG
  • Stryker Corporation
  • Wellong Instruments Co., Ltd.
Product Code: MRR-957C47F8FEC9

The Acute External Ventricular Drain Market is projected to grow by USD 555.51 million at a CAGR of 8.43% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 315.10 million
Estimated Year [2026] USD 340.81 million
Forecast Year [2032] USD 555.51 million
CAGR (%) 8.43%

Acute External Ventricular Drain Executive Summary

Acute external ventricular drain (EVD) systems are critical neurosurgical devices used for temporary cerebrospinal fluid (CSF) diversion and intracranial pressure (ICP) monitoring in patients with life-threatening neurological conditions, including traumatic brain injury, aneurysmal subarachnoid hemorrhage, intraventricular hemorrhage, acute hydrocephalus, central nervous system infection, and post-operative neurosurgical complications. In acute care settings, EVD placement supports rapid ICP control, facilitates CSF sampling, and enables clinicians to respond to secondary brain injury risks through close neurological monitoring.

The acute external ventricular drain landscape is being shaped by rising demand for neurocritical care capacity, increasing recognition of standardized EVD management protocols, infection prevention priorities, and growing adoption of digital monitoring workflows. Clinical guidance from neurological, neurosurgical, and critical care societies consistently emphasizes sterile insertion technique, closed drainage systems, accurate leveling and zeroing, vigilant ICP waveform interpretation, and coordinated nursing-neurosurgery workflows. These priorities are central to improving patient safety, reducing catheter-associated ventriculitis risk, and optimizing outcomes in emergency neurosurgery and intensive care units.

For healthcare providers, procurement teams, device developers, and policy stakeholders, the EVD category sits at the intersection of neurosurgical intervention, infection control, neuro-ICU workflow efficiency, and data-enabled acute care. SEO-relevant themes defining the sector include acute external ventricular drain systems, CSF drainage devices, intracranial pressure monitoring, hydrocephalus treatment, neurocritical care devices, ventricular catheter management, EVD infection prevention, and external ventricular drainage protocols.

Transformative Shifts in the Acute EVD Landscape

The acute EVD landscape is moving from procedure-centric deployment toward protocol-driven, digitally supported neurocritical care. Hospitals are placing greater emphasis on evidence-based EVD bundles that include standardized insertion checklists, antimicrobial stewardship, sterile dressing maintenance, closed-system handling, and clear criteria for CSF sampling. This shift reflects a broader healthcare focus on reducing device-associated infections, strengthening patient safety governance, and minimizing unwarranted clinical variation.

A second transformative shift is the integration of EVD management with high-acuity monitoring environments. Neuro-ICUs increasingly rely on continuous ICP assessment, multimodal neuromonitoring, electronic medical records, and alarm-based escalation pathways to support faster intervention. As a result, device selection is increasingly influenced by usability, drainage accuracy, catheter visibility, compatibility with ICU monitoring systems, pressure transducer reliability, and training requirements for nurses and physicians.

The third shift involves a stronger focus on patient-specific care pathways. Management strategies are increasingly differentiated by disease state, such as aneurysmal subarachnoid hemorrhage, traumatic brain injury, intraventricular hemorrhage, acute hydrocephalus, and post-surgical CSF diversion. In parallel, health systems are evaluating EVD performance through safety indicators, infection surveillance, catheter obstruction events, CSF leak prevention, workflow burden, and adherence to neurocritical care protocols rather than through product features alone.

Cumulative Impact of Artificial Intelligence on Acute EVD Care

Artificial intelligence is beginning to influence the acute external ventricular drain ecosystem through clinical decision support, predictive analytics, image-guided planning, workflow automation, and quality monitoring. In neurocritical care, AI-enabled models are being explored to analyze ICP trends, waveform patterns, neurological observations, laboratory data, imaging findings, medication exposure, and ventilatory parameters to identify deterioration risk earlier than conventional threshold-based monitoring alone.

In EVD placement and management, AI has potential to enhance trajectory planning, catheter positioning assessment, complication detection, and protocol adherence. Computer vision and imaging analytics can support ventricular anatomy evaluation on CT and MRI, while natural language processing can help extract EVD-related events from clinical notes for quality improvement and infection surveillance. AI-enabled dashboards may also help teams track drainage output, ICP variability, sampling frequency, CSF appearance, clamping trials, and documentation completeness across ICU shifts.

The cumulative impact of AI is expected to be operational rather than purely technological: reducing documentation burden, supporting earlier recognition of catheter obstruction or overdrainage risk, strengthening infection-prevention compliance, and improving consistency across multidisciplinary teams. However, deployment must remain clinically governed, transparent, validated in acute neurological populations, and aligned with medical device regulations, cybersecurity expectations, data protection requirements, and human-in-the-loop oversight.

Key Regional Insights for Acute External Ventricular Drain Adoption

Asia-Pacific is characterized by expanding neurosurgical capacity, rising stroke and traumatic brain injury burden, and uneven access to advanced neurocritical care between metropolitan tertiary hospitals and rural or resource-limited settings. Countries with large aging populations and increasing emergency care investments are strengthening demand for acute CSF drainage, ICP monitoring, and hydrocephalus intervention capabilities, while training, affordability, neuroimaging availability, and referral infrastructure remain important adoption determinants.

Europe benefits from well-established neurosurgical networks, regulatory oversight, and strong emphasis on hospital-acquired infection reduction. EVD use is supported by comprehensive stroke care, trauma systems, neurosurgical training standards, and quality assurance programs, though adoption patterns vary across Western, Central, Southern, and Eastern Europe according to reimbursement structures, hospital infrastructure, medical device procurement processes, and intensive care capacity.

North America demonstrates mature use of acute external ventricular drains across trauma centers, comprehensive stroke centers, and academic neuro-ICUs. The region's clinical environment is strongly shaped by infection-control metrics, electronic health record integration, standardized nursing protocols, and continuous quality improvement programs. Adoption decisions commonly emphasize patient safety, compatibility with monitoring infrastructure, regulatory compliance, and adherence to evidence-informed neurocritical care pathways.

Latin America shows growing demand for EVD systems driven by neurosurgical modernization, urban tertiary care expansion, road traffic injury management, and stroke care development. Access remains heterogeneous, with advanced capabilities concentrated in major hospitals, while public-sector procurement constraints, specialist availability, ICU bed access, and infection-control resources influence EVD utilization and maintenance practices.

Africa presents a highly diverse EVD landscape, where major academic and referral hospitals perform acute CSF diversion but many regions face constraints in neurosurgical workforce density, ICU capacity, device availability, infection-control resources, and timely neuroimaging access. International neurosurgical capacity-building, trauma care development, hydrocephalus treatment initiatives, and emergency referral strengthening are relevant drivers for improved access to safe EVD care.

The Middle East is strengthening acute neurosurgical and intensive care capabilities through investment in tertiary hospitals, trauma systems, and specialist workforce development. High-income Gulf states are prioritizing advanced ICU infrastructure and quality-accredited hospital systems, while broader regional adoption is shaped by referral networks, import dependency, reimbursement variability, and access to trained neurocritical care personnel.

Key Group Insights Across NATO, G7, BRICS, EU, ASEAN, and GCC

NATO member countries, particularly those with developed military and civilian trauma systems, emphasize rapid neurotrauma management, standardized emergency response, and critical care readiness. EVD relevance in this group is linked to traumatic brain injury care, neurosurgical interoperability, disaster preparedness, rehabilitation pathways, and quality-controlled acute care protocols across civilian and defense health systems.

G7 countries generally exhibit mature neurocritical care systems, established trauma and stroke pathways, advanced hospital infrastructure, and strong clinical governance around EVD insertion, monitoring, and infection prevention. These economies place significant emphasis on safety evidence, clinician usability, regulatory compliance, cybersecurity readiness, post-market vigilance, and integration with digital hospital systems.

BRICS countries collectively represent a broad spectrum of EVD adoption conditions, ranging from highly advanced neurosurgical centers to regions with infrastructure gaps. Shared drivers include large population needs, traumatic brain injury incidence, stroke burden, public hospital modernization, specialist training expansion, and domestic healthcare capacity building, while access equity, procurement variability, ICU availability, and reimbursement differences remain important considerations.

The European Union provides a structured regulatory and clinical environment for EVD adoption, with strong attention to medical device safety, post-market surveillance, hospital infection control, and cross-border clinical standards. EU healthcare systems commonly prioritize evidence-based procurement, protocol adherence, antimicrobial resistance prevention, and integration with established neurosurgical and intensive care networks.

ASEAN countries reflect a mixed acute EVD environment, with advanced neurosurgical services concentrated in larger urban hospitals and expanding demand linked to trauma, stroke, infection-related hydrocephalus, and pediatric-to-adult neurosurgical care transitions. Regional priorities include workforce training, affordable device access, infection prevention, telemedicine-enabled referral coordination, and stronger pathways for emergency neurological care.

The GCC demonstrates high investment in hospital infrastructure, trauma systems, and specialized critical care, supporting adoption of advanced neuro-ICU practices and EVD management protocols. Demand is shaped by emergency neurosurgery readiness, accreditation-led quality programs, imported medical technology reliance, digital hospital modernization, and growing emphasis on local specialist training.

Key Country Insights for Acute External Ventricular Drain Use

China is expanding neurosurgical and intensive care capacity at scale, supported by major investments in tertiary hospitals, stroke centers, emergency medicine infrastructure, and digital hospital systems. The United States has a highly developed acute EVD environment supported by extensive neuro-ICU capacity, trauma center networks, stroke certification programs, and strong infection-prevention surveillance; clinical adoption is shaped by protocolized ICP monitoring, multidisciplinary ICU teams, digital documentation, and attention to catheter-associated infection reduction. Japan has mature neurosurgical systems, a large aging population, and strong stroke care infrastructure, making EVD management highly relevant in acute hydrocephalus and hemorrhagic neurological emergencies.

India is marked by strong demand from trauma, neuroinfection, hydrocephalus, and hemorrhagic stroke, with advanced EVD care concentrated in metropolitan specialty hospitals and affordability influencing broader access. Germany combines high hospital density, advanced neurosurgery, and robust ICU infrastructure, while the United Kingdom benefits from centralized neurosurgical services, national clinical governance, and strong infection-control practices. Australia relies on well-developed tertiary referral networks, trauma systems, and ICU standards, supporting consistent acute external ventricular drainage practices in specialist centers. France emphasizes specialist hospital networks and protocol-based acute neurological care, while South Korea combines advanced hospital technology, strong neurosurgical capability, and digital health infrastructure that supports high-acuity monitoring and standardized EVD management.

Italy and Spain demonstrate established EVD use through trauma, stroke, and neurosurgical referral systems supported by public healthcare frameworks. Canada shows a strong emphasis on standardized neurosurgical care, provincial health system procurement, infection prevention, and access through regionalized tertiary centers, with geographic distribution influencing emergency neurosurgical availability. Russia maintains significant neurosurgical capacity across major urban centers, although access varies by region and hospital infrastructure. Brazil and Mexico are advancing neurosurgical and critical care capabilities in major urban hospitals, where EVD use is tied to trauma, hemorrhagic stroke, hydrocephalus, and emergency neurosurgery; Brazil's large public-private healthcare mix creates variation in access, while Mexico's tertiary centers support growing adoption of modern neurocritical care protocols.

Actionable Recommendations for Acute EVD Industry Leaders

Industry leaders should prioritize clinically validated innovation that improves safety, workflow efficiency, and consistency in acute EVD care. Product development should focus on infection-risk reduction, secure closed-system design, reliable drainage control, catheter visibility, ease of leveling and monitoring, pressure measurement accuracy, secure connections, and compatibility with ICU digital infrastructure. Usability testing with neurosurgeons, intensivists, and neurocritical care nurses is essential because bedside handling directly influences patient safety.

Healthcare organizations should strengthen EVD care bundles that standardize insertion, maintenance, CSF sampling, dressing changes, line access, drainage height adjustments, clamping trials, troubleshooting, and removal criteria. Regular staff training, competency validation, simulation-based practice, and audit-feedback loops can reduce variation across shifts and care teams. Procurement teams should evaluate devices not only on acquisition cost but also on infection prevention, nursing workload, training needs, documentation support, regulatory compliance, and compatibility with existing monitoring systems.

AI and digital health investments should be pursued with clear clinical governance. Leaders should validate algorithms in neurocritical care populations, maintain human oversight, protect patient data, and ensure transparent escalation logic. Partnerships with hospitals, regulators, and clinical societies can support evidence generation, post-market surveillance, interoperability, and responsible adoption of connected EVD monitoring solutions.

Research Methodology for Acute External Ventricular Drain Analysis

The research methodology for analyzing the acute external ventricular drain landscape is grounded in secondary and primary evidence synthesis. Secondary research includes peer-reviewed neurosurgery and neurocritical care literature, clinical practice guidelines, hospital infection-control standards, medical device regulatory documents, public health data on neurological disease burden, trauma and stroke care frameworks, ICU quality improvement publications, and health system infrastructure references. Emphasis is placed on verified sources such as clinical societies, government health agencies, regulatory authorities, public health institutions, and indexed scientific journals.

Primary research may include structured discussions with neurosurgeons, neurointensivists, ICU nurses, hospital procurement specialists, biomedical engineers, infection-prevention professionals, and healthcare administrators. These insights help contextualize device selection criteria, workflow challenges, training requirements, safety priorities, clinical documentation needs, and regional adoption barriers.

The analytical approach triangulates clinical evidence, regulatory considerations, hospital workflow dynamics, and regional healthcare infrastructure indicators. The methodology avoids unsupported extrapolation and does not rely on market sizing, market share, or forecasting. Findings are interpreted through the lens of patient safety, clinical utility, access to neurocritical care, infection prevention maturity, and technology readiness across healthcare systems.

Conclusion: Advancing Safer Acute External Ventricular Drain Care

Acute external ventricular drain systems remain indispensable in emergency neurosurgery and neurocritical care, enabling temporary CSF diversion and intracranial pressure monitoring for patients at risk of rapid neurological deterioration. The sector is evolving toward safer, more standardized, and digitally enabled care models, with infection prevention, workflow reliability, accurate ICP monitoring, and multidisciplinary protocol adherence serving as defining priorities.

Regional and country-level dynamics show that mature healthcare systems are focusing on quality optimization, digital integration, and evidence-based procurement, while emerging healthcare systems are prioritizing access, training, ICU capacity, timely neuroimaging, and affordable availability. Across all settings, the strongest opportunities lie in solutions that improve bedside safety, reduce variability, support clinical decision-making, and fit seamlessly into high-pressure acute care workflows.

As AI, connected monitoring, and data-driven quality programs become more relevant, success in the acute EVD landscape will depend on clinically validated innovation, regulatory discipline, cybersecurity readiness, and close alignment with the realities of neurocritical care delivery. Stakeholders that combine device reliability with infection prevention, usability, and actionable clinical intelligence will be best positioned to support safer outcomes in acute neurological emergencies.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Acute External Ventricular Drain Market, by Product Type

  • 7.1. Introduction
  • 7.2. External Ventricular Drainage Systems
  • 7.3. Ventricular Catheters
  • 7.4. Drainage Collection Systems
  • 7.5. Accessories
    • 7.5.1. Connectors & Stopcocks
    • 7.5.2. Trocars

8. Acute External Ventricular Drain Market, by Procedure Type

  • 8.1. Introduction
  • 8.2. Emergency Ventricular Drainage
  • 8.3. Temporary CSF Drainage
  • 8.4. Post-neurosurgical Drainage
  • 8.5. ICP Monitoring Procedures
  • 8.6. Hydrocephalus Management

9. Acute External Ventricular Drain Market, by Drainage Type

  • 9.1. Introduction
  • 9.2. Continuous Drainage
  • 9.3. Intermittent Drainage

10. Acute External Ventricular Drain Market, by Application

  • 10.1. Introduction
  • 10.2. Hydrocephalus Management
  • 10.3. Intracranial Pressure Monitoring
  • 10.4. Subarachnoid Hemorrhage Treatment
  • 10.5. Traumatic Brain Injury Management

11. Acute External Ventricular Drain Market, by End User

  • 11.1. Introduction
  • 11.2. Ambulatory Surgical Centers
  • 11.3. Hospitals
  • 11.4. Specialty Clinics

12. Acute External Ventricular Drain Market, by Patient Age Group

  • 12.1. Introduction
  • 12.2. Adult
  • 12.3. Pediatric

13. Acute External Ventricular Drain Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. Europe
  • 13.3. North America
  • 13.4. Latin America
  • 13.5. Africa
  • 13.6. Middle East

14. Acute External Ventricular Drain Market, by Group

  • 14.1. NATO
  • 14.2. G7
  • 14.3. BRICS
  • 14.4. European Union
  • 14.5. ASEAN
  • 14.6. GCC

15. Acute External Ventricular Drain Market, by Country

  • 15.1. China
  • 15.2. United States
  • 15.3. Japan
  • 15.4. India
  • 15.5. Germany
  • 15.6. United Kingdom
  • 15.7. Australia
  • 15.8. France
  • 15.9. South Korea
  • 15.10. Italy
  • 15.11. Canada
  • 15.12. Russia
  • 15.13. Brazil
  • 15.14. Mexico
  • 15.15. Spain

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2025
  • 16.2. FPNV Positioning Matrix, 2025
  • 16.3. Market Concentration Analysis, 2025
    • 16.3.1. Concentration Ratio (CR)
    • 16.3.2. Herfindahl Hirschman Index (HHI)
  • 16.4. Recent Developments & Impact Analysis, 2025
  • 16.5. Product Portfolio Analysis, 2025
  • 16.6. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Argi Grup
  • 17.2. B. Braun SE
  • 17.3. Christoph Miethke GmbH & Co. KG
  • 17.4. Cook Medical LLC
  • 17.5. Desu Medical
  • 17.6. Fuji Systems Corporation
  • 17.7. Integra LifeSciences Holdings Corporation
  • 17.8. Medtronic plc
  • 17.9. Moller Medical GmbH
  • 17.10. Natus Medical Incorporated
  • 17.11. Neuromedex GmbH
  • 17.12. Raumedic AG
  • 17.13. Sophysa
  • 17.14. Spiegelberg GmbH & Co. KG
  • 17.15. Stryker Corporation
  • 17.16. Wellong Instruments Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 25. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL EXTERNAL VENTRICULAR DRAINAGE SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL EXTERNAL VENTRICULAR DRAINAGE SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL EXTERNAL VENTRICULAR DRAINAGE SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL VENTRICULAR CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL VENTRICULAR CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL VENTRICULAR CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DRAINAGE COLLECTION SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DRAINAGE COLLECTION SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DRAINAGE COLLECTION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ACCESSORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ACCESSORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CONNECTORS & STOPCOCKS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CONNECTORS & STOPCOCKS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CONNECTORS & STOPCOCKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL TROCARS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL TROCARS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL TROCARS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL EMERGENCY VENTRICULAR DRAINAGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL EMERGENCY VENTRICULAR DRAINAGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL EMERGENCY VENTRICULAR DRAINAGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL TEMPORARY CSF DRAINAGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL TEMPORARY CSF DRAINAGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL TEMPORARY CSF DRAINAGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL POST-NEUROSURGICAL DRAINAGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL POST-NEUROSURGICAL DRAINAGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL POST-NEUROSURGICAL DRAINAGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ICP MONITORING PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ICP MONITORING PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ICP MONITORING PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HYDROCEPHALUS MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HYDROCEPHALUS MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HYDROCEPHALUS MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CONTINUOUS DRAINAGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CONTINUOUS DRAINAGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CONTINUOUS DRAINAGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INTERMITTENT DRAINAGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTERMITTENT DRAINAGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INTERMITTENT DRAINAGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HYDROCEPHALUS MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HYDROCEPHALUS MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HYDROCEPHALUS MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRACRANIAL PRESSURE MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INTRACRANIAL PRESSURE MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRACRANIAL PRESSURE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SUBARACHNOID HEMORRHAGE TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SUBARACHNOID HEMORRHAGE TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SUBARACHNOID HEMORRHAGE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL TRAUMATIC BRAIN INJURY MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL TRAUMATIC BRAIN INJURY MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL TRAUMATIC BRAIN INJURY MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 128. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 136. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 166. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 168. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. CHINA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 175. CHINA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 177. CHINA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. CHINA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. CHINA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. CHINA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. CHINA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 190. JAPAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. JAPAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. JAPAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 193. JAPAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. JAPAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. JAPAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. JAPAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. JAPAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. INDIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 199. INDIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. INDIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 201. INDIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. INDIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. INDIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. INDIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. INDIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 206. GERMANY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 207. GERMANY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. GERMANY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 209. GERMANY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. GERMANY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. GERMANY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. GERMANY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. GERMANY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED KINGDOM ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED KINGDOM ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED KINGDOM ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED KINGDOM ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED KINGDOM ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED KINGDOM ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED KINGDOM ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED KINGDOM ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 222. AUSTRALIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 223. AUSTRALIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. AUSTRALIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 225. AUSTRALIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. AUSTRALIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. AUSTRALIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. AUSTRALIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. AUSTRALIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 230. FRANCE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 231. FRANCE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. FRANCE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 233. FRANCE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. FRANCE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. FRANCE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. FRANCE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. FRANCE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 238. SOUTH KOREA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 239. SOUTH KOREA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. SOUTH KOREA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 241. SOUTH KOREA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. SOUTH KOREA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. SOUTH KOREA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. SOUTH KOREA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. SOUTH KOREA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 246. ITALY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 247. ITALY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. ITALY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 249. ITALY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. ITALY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. ITALY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 252. ITALY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. ITALY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 254. CANADA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 255. CANADA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. CANADA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 257. CANADA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. CANADA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. CANADA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 260. CANADA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. CANADA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 262. RUSSIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 263. RUSSIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. RUSSIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 265. RUSSIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. RUSSIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. RUSSIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 268. RUSSIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. RUSSIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 270. BRAZIL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 271. BRAZIL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. BRAZIL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 273. BRAZIL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. BRAZIL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. BRAZIL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. BRAZIL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 277. BRAZIL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 278. MEXICO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 279. MEXICO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. MEXICO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 281. MEXICO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. MEXICO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 283. MEXICO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 284. MEXICO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 285. MEXICO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 286. SPAIN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 287. SPAIN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. SPAIN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 289. SPAIN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. SPAIN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. SPAIN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 292. SPAIN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 293. SPAIN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 294. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SHARE, BY KEY PLAYER, 2025
  • TABLE 295. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025